» Articles » PMID: 33273617

Characterization of a Novel Yeast Phase-specific Antigen Expressed During in Vitro Thermal Phase Transition of Talaromyces Marneffei

Overview
Journal Sci Rep
Specialty Science
Date 2020 Dec 4
PMID 33273617
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Talaromyces marneffei is a dimorphic fungus that has emerged as an opportunistic pathogen particularly in individuals with HIV/AIDS. Since its dimorphism has been associated with its virulence, the transition from mold to yeast-like cells might be important for fungal pathogenesis, including its survival inside of phagocytic host cells. We investigated the expression of yeast antigen of T. marneffei using a yeast-specific monoclonal antibody (MAb) 4D1 during phase transition. We found that MAb 4D1 recognizes and binds to antigenic epitopes on the surface of yeast cells. Antibody to antigenic determinant binding was associated with time of exposure, mold to yeast conversion, and mammalian temperature. We also demonstrated that MAb 4D1 binds to and recognizes conidia to yeast cells' transition inside of a human monocyte-like THP-1 cells line. Our studies are important because we demonstrated that MAb 4D1 can be used as a tool to study T. marneffei virulence, furthering the understanding of the therapeutic potential of passive immunity in this fungal pathogenesis.

Citing Articles

An unusual Toll/MyD88-mediated host defence against .

Wang X, Qu Q, Li Z, Lu S, Ferrandon D, Xi L Fly (Austin). 2024; 18(1):2398300.

PMID: 39239739 PMC: 11382710. DOI: 10.1080/19336934.2024.2398300.


The microbial damage and host response framework: lesson learned from pathogenic survival trajectories and immunoinflammatory responses of infection.

Pruksaphon K, Amsri A, Jeenkeawpieam J, Thammasit P, Nosanchuk J, Youngchim S Front Immunol. 2024; 15:1448729.

PMID: 39188728 PMC: 11345217. DOI: 10.3389/fimmu.2024.1448729.


Talaromyces marneffei suppresses macrophage inflammation by regulating host alternative splicing.

Wei W, Wang G, Zhang H, Bao X, An S, Luo Q Commun Biol. 2023; 6(1):1046.

PMID: 37845378 PMC: 10579421. DOI: 10.1038/s42003-023-05409-6.


Evaluation of the yeast phase-specific monoclonal antibody 4D1 and agglutinin sandwich ELISA to detect antigen in human urine.

Shu F, Pruksaphon K, Nosanchuk J, Thammasit P, Youngchim S Front Cell Infect Microbiol. 2023; 13:1163868.

PMID: 37705932 PMC: 10495985. DOI: 10.3389/fcimb.2023.1163868.


Extracellular vesicles derived from contain immunogenic compounds and modulate THP-1 macrophage responses.

Pruksaphon K, Amsri A, Thammasit P, Nosanchuk J, Youngchim S Front Immunol. 2023; 14:1192326.

PMID: 37457708 PMC: 10339390. DOI: 10.3389/fimmu.2023.1192326.


References
1.
Pruksaphon K, Intaramat A, Ratanabanangkoon K, Nosanchuk J, Vanittanakom N, Youngchim S . Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei. PLoS One. 2018; 13(4):e0195596. PMC: 5895032. DOI: 10.1371/journal.pone.0195596. View

2.
San-Blas G, Travassos L, Fries B, Goldman D, Casadevall A, Carmona A . Fungal morphogenesis and virulence. Med Mycol. 2001; 38 Suppl 1:79-86. View

3.
Pruksaphon K, Intaramat A, Ratanabanangkoon K, Nosanchuk J, Vanittanakom N, Youngchim S . Diagnostic laboratory immunology for talaromycosis (penicilliosis): review from the bench-top techniques to the point-of-care testing. Diagn Microbiol Infect Dis. 2019; 96(3):114959. DOI: 10.1016/j.diagmicrobio.2019.114959. View

4.
Tsang C, Lau S, Woo P . Sixty Years from Segretain's Description: What Have We Learned and Should Learn About the Basic Mycology of Talaromyces marneffei?. Mycopathologia. 2019; 184(6):721-729. DOI: 10.1007/s11046-019-00395-y. View

5.
Dong R, Zhang Y, Zhu L, Liu H, Liu J, Kuang Y . Innate Immunity Acts as the Major Regulator in Coinfected AIDS Patients: Cytokine Profile Surveillance During Initial 6-Month Antifungal Therapy. Open Forum Infect Dis. 2019; 6(6):ofz205. PMC: 6559339. DOI: 10.1093/ofid/ofz205. View